トップ > 製品検索結果一覧 > Code No. M061-3 Anti-Selenium Binding Protein mAb

Code No.　M061-3

Anti-Selenium Binding Protein mAb

価格（税別）

¥52,800

在庫

10以上

（2024/04/20 17:00時点）

包装

100 µL (1 mg/mL)

データ

  • Western Blotting
クローナリティー Monoclonal クローン 4D4
アイソタイプ
（免疫動物） 		Mouse IgG1
使用法
WB
1 µg/mL  
IH
2 µg/mL  
免疫原(抗原) Recombinant full length Human SBP
交差性
[Gene ID]

Human[8991], Mouse(w)[20341], Rat[140927]
性状 1 mg/mL in PBS/50% glycerol, pH 7.2
保存温度 -20°C 標識 Unlabeled メーカー MBL
別称 SELENBP1, selenium binding protein 1, LPSB, SP56, hSBP, SBP56, 56 kDa selenium-binding protein/Lp56, SBP56/Selenbp2
使用文献
 使用文献募集中！本製品を使って論文を発表されましたら是非お知らせください。

Western Blotting

  1. Chen G et al. Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas. J Pathol. 202, 321-9 (2004)(PMID:14991897)
  2. Huang KC et al. Selenium binding protein 1 in ovarian cancer. Int J Cancer 118, 2433-40 (2006)(PMID:16380993)
  3. Kim H et al. Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics 6, 3466-76 (2006)(PMID:16645984)
  4. Stammer K et al. Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer. Gynecol Oncol. 109, 115-21 (2008)(PMID:18272210)
  5. Li T et al. Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. Mol Nutr Food Res. 52, 1289-99 (2008)(PMID:18435490)
  6. Silvers AL et al. Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity. Clin Cancer Res 16, 2009-21 (2010)(PMID:20332323)
  7. Zhang S et al. Reduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of selenium. PLoS One 8, e63702 (2013)(PMID:23704933)
  8. Steinbrenner H et al. Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes. Redox Biol.20, 489-495 (2019)(PMID:30469030)
  9. Zhang XY et al. Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transition. Am J Transl Res. 10, 3567-3578 (2018) (PMID:30662608)
  10. Steinbrenner H et al. Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes. Redox Biol. 20 489-495 (2019)(PMID:30469030)

Immunocytochemistry

  1. Steinbrenner H et al. Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes. Redox Biol.20, 489-495 (2019)(PMID:30469030)
  2. Steinbrenner H et al. Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes. Redox Biol. 20 489-495 (2019)(PMID:30469030)

Immunohistochemistry

  1. Chen G et al. Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas. J Pathol. 202, 321-9 (2004)(PMID:14991897)
  2. Glatt SJ et al. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. PNAS 102, 15533-8 (2005)(PMID:16223876)
  3. Huang KC et al. Selenium binding protein 1 in ovarian cancer. Int J Cancer 118, 2433-40 (2006)(PMID:16380993)
  4. Kim H et al. Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics 6, 3466-76 (2006)(PMID:16645984)
  5. Stammer K et al. Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer. Gynecol Oncol. 109, 115-21 (2008)(PMID:18272210)
  6. Li T et al. Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. Mol Nutr Food Res. 52, 1289-99 (2008)(PMID:18435490)
  7. Zhang C et al. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma. Hum Pathol. 41, 255-61 (2010)(PMID:19896693)
  8. Silvers AL et al. Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity. Clin Cancer Res 16, 2009-21 (2010)(PMID:20332323)
  9. Raucci R et al. Structural and functional studies of the human selenium binding protein-1 and its involvement in hepatocellular carcinoma. Biochim Biophys Acta 1814, 513-22 (2011)(PMID:21338716)
  10. Zhang XY et al. Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transition. Am J Transl Res. 10, 3567-3578 (2018)(PMID:30662608)
製品
カテゴリー
分野
がん
この製品に関するお問い合わせをする

※在庫につきましては2024年04月20日 17時00分時点における在庫数を表示してあります。
※価格の赤色表示につきましては、キャンペーン価格の表示となっております。
※このサイトからは直接注文はできません。ご注意ください。
※使用法の表記について：
WB: Western Blotting, IH: Immunohistochemistry, IC: Immunocytochemistry, IP: Immunoprecipitation,
FCM: Flow Cytometry NT: Neutralization, IF: Immunofluorescence, RIP: RNP Immunoprecipitation,
ChIP: Chromatin Immunoprecipitation, CoIP: Co-Immunoprecipitation
DB: Dot Blotting, NB: Northern Blotting, RNA FISH: RNA Fluorescence in situ hybridization
※使用法・交差性の表記について：
*: 論文で報告されております（MBLでは未確認）。詳しくはデータシートをご覧ください。
**: 導入元からの情報です（MBLでは評価中もしくは未確認）。
※保存温度の表記について： RT: 室温
※本サイトの掲載製品は、品質改良のため予告なく仕様などの変更、または販売中止となる場合がございます。あらかじめご了承ください。